Ask AI
Bill114th CongressFiled Oct 1, 2015Health
H.R. 3680

Co-Prescribing to Reduce Overdoses Act of 2016

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary passed house amended (May 11, 2016)

Co-Prescribing to Reduce Overdoses Act of 2016

(Sec. 2) This bill permits the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists, track patients and outcomes, offset patient cost sharing, conduct community outreach, and connect patients to treatment.

(Sec. 3) HHS may provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing opioid overdose reversal drugs for patients at an elevated risk of overdose.

(Sec. 4) This bill amends the Public Health Service Act to reduce, as an offset, the authorization of appropriations for Centers for Disease Control and Prevention facilities for FY2018.

What just happenedMay 12, 2016

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Who’s behind it

Rep. Sarbanes, John P. [D-MD-3](D-MD)Sponsor
5 cosponsors5 R
Read on Congress.gov
5cosponsors2committees21actions5related bills6subjects
  1. May 12, 2016IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. May 11, 2016FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. May 11, 2016FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2256-2257)

  4. May 11, 2016Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2256-2257)

  5. May 11, 2016FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 3680.

  6. May 11, 2016FloorH30000

    Considered under suspension of the rules. (consideration: CR H2256-2259)

  7. May 11, 2016FloorH30300

    Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

  8. May 10, 2016CalendarsH12410

    Placed on the Union Calendar, Calendar No. 427.

  9. May 10, 2016CommitteeH12200

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-553.

    Energy and Commerce Committee
  10. May 10, 2016Committee5000

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-553.

    Energy and Commerce Committee
  11. Apr 28, 2016Committee

    Ordered to be Reported (Amended) by Voice Vote.

    Energy and Commerce Committee
  12. Apr 28, 2016Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  13. Apr 27, 2016Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  14. Apr 26, 2016Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  15. Apr 25, 2016Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  16. Apr 20, 2016Committee

    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

    Health Subcommittee
  17. Apr 20, 2016Committee

    Subcommittee Consideration and Mark-up Session Held.

    Health Subcommittee
  18. Oct 2, 2015Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  19. Oct 1, 2015IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  20. Oct 1, 2015IntroReferralIntro-H

    Introduced in House

  21. Oct 1, 2015IntroReferral1000

    Introduced in House

Passed House amendedMay 11, 201636

Co-Prescribing to Reduce Overdoses Act of 2016

(Sec. 2) This bill permits the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists, track patients and outcomes, offset patient cost sharing, conduct community outreach, and connect patients to treatment.

(Sec. 3) HHS may provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing opioid overdose reversal drugs for patients at an elevated risk of overdose.

(Sec. 4) This bill amends the Public Health Service Act to reduce, as an offset, the authorization of appropriations for Centers for Disease Control and Prevention facilities for FY2018.

Reported to House with amendment(s)May 10, 201617

Co-Prescribing to Reduce Overdoses Act of 2016

(Sec. 2) This bill permits the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists, track patients and outcomes, offset patient cost sharing, conduct community outreach, and connect patients to treatment.

(Sec. 3) HHS may provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing opioid overdose reversal drugs for patients at an elevated risk of overdose.

(Sec. 4) As an offset, this bill reduces the authorization of appropriations for Centers for Disease Control and Prevention facilities.

Introduced in HouseOct 1, 2015

Co-Prescribing to Reduce Overdoses Act of 2015

This bill requires the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists on prescription of such drugs, track patients and outcomes, and for other specified activities.

HHS must award grants to certain community groups and state and municipal health departments to develop guidelines on prescribing opioid overdose reversal drugs.
Co-Prescribing to Reduce Overdoses Act of 2016 — Informed